Commitments and Contingencies - Contingent Consideration (Details) - USD ($) $ in Thousands |
Jun. 30, 2025 |
Dec. 31, 2024 |
Apr. 30, 2024 |
|---|---|---|---|
| Commitments and Contingencies | |||
| Exarafenib milestone contingent consideration | $ 3,402 | $ 3,214 | |
| Kinnate CVR holders | CVR Agreement | |||
| Commitments and Contingencies | |||
| Exarafenib milestone contingent consideration | $ 3,400 | $ 3,200 |
| X | ||||||||||
- Definition Amount of liability recognized from contingent consideration in asset acquisition, classified as noncurrent. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|